在血液透析中具有潜在应用的皇冠乙功能聚硫膜
Madalina Oprea1,2, Andreea Madalina Pandele1,2, Catalin Ionel Enachescu3
1Advanced Polymers Materials Group, National University of Science and Technology POLITEHNICA Bucharest, 1-7 Gheorghe Polizu, 011061 Bucharest, Romania.
Polymers
|August 28, 2025
概括
研究人员通过添加皇冠来改善聚硫 (PES) 血液透析膜,以减少血液凝固. 这种修改可提高离子的保留率,这是血液凝固的关键因素,高达30%.
科学领域:
- 生物材料科学
- 聚合物化学
- 医疗设备工程
背景情况:
- 由于其生物相容性和高透性,聚乙硫 (PES) 在血液透析膜中被广泛使用.
- 目前的PES膜需要提高抗凝固性能, 以尽量减少与血液有关的并发症.
- 血液凝固涉及离子 (Ca2+),使其复合成为抗凝剂策略的目标.
研究的目的:
- 增强聚乙硫 (PES) 血液透析膜的抗凝性能.
- 研究用皇冠乙烯对Ca2+复合物的化学修饰的有效性.
- 描述改造的膜,并评估它们的离子保留能力.
主要方法:
- 使用和氨的商业PES膜的等离子处理.
- 用4'-aminobenzo-15-crown-5处理的膜的化学功能化.
- 使用FT-IR,XPS,TGA,SEM和CT进行物理化学和形态特征.
- 使用诱导联等离子质谱法 (ICP-MS) 评估离子保留.
主要成果:
- 血处理有效地将含的功能组引入PES表面.
- 这些功能组促进了皇冠以太的成功共价附着.
- 修改后的PES膜的离子 (Ca2+) 保留率增加了多达30%.
结论:
- 血治疗之后的皇冠改是一种可行的策略,以改善PES血液透析膜的特性.
- 增强的Ca2+保留表明抗凝剂性能有所改善,可能降低血栓性.
- 这种方法为开发更安全,更有效的血液透析膜提供了一个有前途的途径.
相关概念视频
Crown Ethers
5.4K
Crown ethers are cyclic polyethers that contain multiple oxygen atoms, usually arranged in a regular pattern. The first crown ether was synthesized by Charles Pederson while working at DuPont in 1967. For this work, Pedersen was co-awarded the 1987 Nobel Prize in Chemistry. Crown ethers are named using the formula x-crown-y, where x is the total number of atoms in the ring and y is the number of ether oxygen atoms. The term 'crown' refers to the crown-like shape that these ether...
5.4K
Dialysis
803
Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...
803
Hemodialysis II: Procedure and Complications
128
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
128
Hemodialysis I: Introduction
282
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
282
Ion Exchange
657
Ion exchange chromatography separates charged molecules from a solution by reversibly exchanging them with mobile, or 'active', ions associated with the oppositely charged stationary phase. This method can be used to separate ions, soften and deionize water, and purify solutions. The polymers comprising the ion-exchange column are high-molecular-weight and chemically stable polymers, crosslinked to be porous and essentially insoluble. They are also functionalized with either acidic or...
657
Peritoneal Dialysis I: Introduction and Procedure
197
Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
197


